文献速递其他结缔组织病

特发性炎症性肌病患者身体功能受损:多中心COVAD患者报告电子调查结果

Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
PubMed 文献 · Rheumatology (Oxford) · 2023-01-01

基于COVAD国际电子调查数据,比较1057例特发性炎症性肌病患者、3635例非特发性炎症性肌病自身免疫风湿病患者和3981名健康对照的PROMIS身体功能评分。特发性炎症性肌病患者预测平均评分显著低于非特发性炎症性肌病自身免疫风湿病患者和健康对照,且不依赖疾病活动度;疾病非活动期患者中,年龄较大、女性、病程较长及包涵体肌炎或多发性肌炎诊断与较低评分独立相关。

要点

  • 特发性炎症性肌病患者PROMIS身体功能评分显著低于非特发性炎症性肌病自身免疫风湿病患者和健康对照
  • 即使疾病非活动,特发性炎症性肌病患者身体功能仍显著受损
  • 疾病非活动期低评分的独立因素包括年龄较大、女性、病程较长、包涵体肌炎或多发性肌炎

核心结论

  • 与特发性炎症性肌病以外的自身免疫风湿病或健康对照相比,特发性炎症性肌病患者身体功能显著受损,即使疾病非活动期亦如此。

研究设计与样本

  • 研究基于COVAD数据库,该数据库为评估自身免疫风湿病患者COVID-19疫苗安全性的国际自我报告电子调查。
  • 提取人口学、自身免疫风湿病诊断、疾病活动度和PROMIS身体功能简表10a数据。
  • 比较不同疾病类别间PROMIS身体功能10a评分,并按疾病活动度分层。
  • 在疾病非活动患者中,通过多变量回归分析识别除疾病活动度外影响PROMIS身体功能10a评分的因素。

主要发现

  • 2021年4月至8月,共1057例特发性炎症性肌病患者、3635例非特发性炎症性肌病自身免疫风湿病患者和3981名健康对照回应COVAD电子调查。
  • 采用二项回归模型,特发性炎症性肌病患者PROMIS身体功能10a评分预测均值显著低于非特发性炎症性肌病自身免疫风湿病患者和健康对照[36.3(95%CI 35.5,37.1)vs 41.3(95%CI 40.2,42.5)vs 46.2(95%CI 45.8,46.6),P<0.001],且不依赖疾病活动度。
  • 疾病非活动患者中,PROMIS身体功能10a评分较低的独立因素为年龄较大、女性、病程较长及包涵体肌炎或多发性肌炎诊断。

关键数值与推荐

  • 特发性炎症性肌病患者PROMIS身体功能10a评分预测均值为36.3(95%CI 35.5,37.1)。
  • 非特发性炎症性肌病自身免疫风湿病患者PROMIS身体功能10a评分预测均值为41.3(95%CI 40.2,42.5)。
  • 健康对照PROMIS身体功能10a评分预测均值为46.2(95%CI 45.8,46.6)。
  • 三组比较P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The assessment of physical function is fundamental in the management of patients with idiopathic inflammatory myopathies (IIMs). We aimed to investigate the physical function of patients with IIMs compared with those with non-IIM autoimmune rheumatic diseases (AIRDs) utilizing Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function (PF) data obtained in the COVAD study, an international self-reported e-survey assessing the safety of COVID-19 vaccines in AIRDs. METHODS: Demographics, AIRD diagnosis, disease activity, and PROMIS PF short form-10a data were extracted from the COVAD database. PROMIS PF-10a scores were compared between disease categories and stratified by disease activity. Factors affecting PROMIS PF-10a scores other than disease activity were identified by multivariable regression analysis in patients with inactive disease. RESULTS: A total of 1057 IIM patients, 3635 non-IIM AIRD patients and 3981 healthy controls (HCs) responded to the COVAD e-survey from April to August 2021. Using a binomial regression model, the predicted mean of PROMIS PF-10a scores was significantly lower in IIM patients compared with non-IIM AIRD patients or HCs [36.3 (95% CI 35.5, 37.1) vs 41.3 (95% CI 40.2, 42.5) vs 46.2 (95% CI 45.8, 46.6), P < 0.001], irrespective of disease activity. The independent factors for lower PROMIS PF-10a scores in patients with inactive disease were older age, female, longer disease duration, and a diagnosis of inclusion body myositis or polymyositis. CONCLUSION: Physical function is significantly impaired in IIMs compared with non-IIM AIRDs or HCs, even in patients with inactive disease. Our study highlights a critical need for better strategies to minimize functional disability in patients with IIMs.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yoshida A, Kim M, Kuwana M, et al. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Rheumatology (Oxford). 2023. PMID: 35920795. doi:10.1093/rheumatology/keac441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。